Die Oldenburgische Landesbank (OLB) hat im vergangenen Jahr offenbar einen Rekordgewinn erzielt. Dahinter standen unter ...
The company will not receive any proceeds from the sale of the shares by the selling stockholders. Invest with Confidence: Follow TipRanks' Top ...
Christoph Rauwald, Michael Nienaber und Arne Delfs über das Wahlkampfthema Nr. 1 — Abonnieren Sie auch unseren Newsletter ...
Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received an average rating of “Buy” from the seven analysts that are presently covering the company, Marketbeat.com reports. Seven investment ...
Vor Bio (NASDAQ:VOR) shares soared more than 20% in Friday pre-market trading, after it said that it has entered into a securities purchase agreement for a private investment in public equity ...
CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase ...
UC&C-Gipfel 2025 von Wildix stellt KI-gestützte Innovationen und vertikale Wachstumsdurchbrüche bei Unified Communications ...
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of ...
Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity ...
https://www.tipranks.com/news/the-fly/kazia-therapeutics-to-sell-1-33m-ads-at-1-50-in-registered-direct-offering The latest announcement is out from Vor Biopharma ...
Vor announced it entered into a securities purchase agreement for a private investment in public equity financing. The company expects to generate about $55.6 million in gross proceeds.
Gameweek seven of the Europa League continued tonight with several high-profile clashes, most notably a Battle of Britain between Manchester United and Rangers at Old Trafford. That's our coverage of ...